401k Plan data: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY plan

SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 401k Plan overview

Plan Name	SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY
Plan identification number	001

SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

HARTIG DRUG COMPANY has sponsored the creation of one or more 401k plans.

Company Name: HARTIG DRUG COMPANY

Employer identification number (EIN): 420298860

NAIC Classification: 446110
NAIC Description: Pharmacies and Drug Stores

Additional information about HARTIG DRUG COMPANY

Jurisdiction of Incorporation: Iowa Secretary of State Business Entities

Incorporation Date: 1917-02-24

Company Identification Number: 017939

Legal Registered Office Address: 703 MAIN ST

DUBUQUE
United States of America (USA)
52001

More information about HARTIG DRUG COMPANY

Form 5500 Filing Information

Submission information for form 5500 for 401k plan SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2023-01-01
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 RICHARD HARTIG
001 2016-01-01 RICHARD HARTIG
001 2015-01-01 RICHARD J HARTIG
001 2014-01-01 RICHARD J HARTIG RICHARD J HARTIG 2015-10-13
001 2013-01-01 RICHARD J HARTIG RICHARD J HARTIG 2014-10-13
001 2012-01-01 RICHARD J HARTIG RICHARD J HARTIG 2013-09-21
001 2011-01-01 RICHARD J HARTIG RICHARD J HARTIG 2012-09-21
001 2010-01-01 RICHARD J HARTIG RICHARD J HARTIG 2011-08-24
001 2009-01-01 RICHARD J HARTIG RICHARD J HARTIG 2010-07-28

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2023-01-01
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	RICHARD HARTIG
001	2016-01-01	RICHARD HARTIG
001	2015-01-01	RICHARD J HARTIG
001	2014-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2015-10-13
001	2013-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2014-10-13
001	2012-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2013-09-21
001	2011-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2012-09-21
001	2010-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2011-08-24
001	2009-01-01	RICHARD J HARTIG	RICHARD J HARTIG	2010-07-28

Plan Statistics for SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY

401k plan membership statisitcs for SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY

Measure Date Value
2023: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2023 401k membership
Total participants, beginning-of-year 2023-01-01 408
Total number of active participants reported on line 7a of the Form 5500 2023-01-01 339
Number of retired or separated participants receiving benefits 2023-01-01 0
Number of other retired or separated participants entitled to future benefits 2023-01-01 55
Total of all active and inactive participants 2023-01-01 394
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2023-01-01 0
Total participants 2023-01-01 394
Number of participants with account balances 2023-01-01 370
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2023-01-01 36
2022: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2022 401k membership
Total participants, beginning-of-year 2022-01-01 416
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 326
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 49
Total of all active and inactive participants 2022-01-01 375
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 375
Number of participants with account balances 2022-01-01 357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 40
2021: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2021 401k membership
Total participants, beginning-of-year 2021-01-01 427
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 369
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 51
Total of all active and inactive participants 2021-01-01 420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 420
Number of participants with account balances 2021-01-01 294
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 21
2020: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2020 401k membership
Total participants, beginning-of-year 2020-01-01 452
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 365
Number of retired or separated participants receiving benefits 2020-01-01 1
Number of other retired or separated participants entitled to future benefits 2020-01-01 31
Total of all active and inactive participants 2020-01-01 397
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 397
Number of participants with account balances 2020-01-01 309
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 7
2019: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2019 401k membership
Total participants, beginning-of-year 2019-01-01 431
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 378
Number of retired or separated participants receiving benefits 2019-01-01 4
Number of other retired or separated participants entitled to future benefits 2019-01-01 141
Total of all active and inactive participants 2019-01-01 523
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 524
Number of participants with account balances 2019-01-01 418
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 20
2018: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2018 401k membership
Total participants, beginning-of-year 2018-01-01 421
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 368
Number of retired or separated participants receiving benefits 2018-01-01 2
Number of other retired or separated participants entitled to future benefits 2018-01-01 50
Total of all active and inactive participants 2018-01-01 420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 2
Total participants 2018-01-01 422
Number of participants with account balances 2018-01-01 297
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 15
2017: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2017 401k membership
Total participants, beginning-of-year 2017-01-01 485
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 420
Number of retired or separated participants receiving benefits 2017-01-01 2
Number of other retired or separated participants entitled to future benefits 2017-01-01 45
Total of all active and inactive participants 2017-01-01 467
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 3
Total participants 2017-01-01 470
Number of participants with account balances 2017-01-01 297
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 16
2016: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2016 401k membership
Total participants, beginning-of-year 2016-01-01 325
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 277
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 38
Total of all active and inactive participants 2016-01-01 315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 316
Number of participants with account balances 2016-01-01 285
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 18
2015: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2015 401k membership
Total participants, beginning-of-year 2015-01-01 266
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 249
Number of retired or separated participants receiving benefits 2015-01-01 2
Number of other retired or separated participants entitled to future benefits 2015-01-01 33
Total of all active and inactive participants 2015-01-01 284
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 284
Number of participants with account balances 2015-01-01 257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 25
2014: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2014 401k membership
Total participants, beginning-of-year 2014-01-01 292
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 250
Number of retired or separated participants receiving benefits 2014-01-01 1
Number of other retired or separated participants entitled to future benefits 2014-01-01 27
Total of all active and inactive participants 2014-01-01 278
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 278
Number of participants with account balances 2014-01-01 262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 15
2013: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2013 401k membership
Total participants, beginning-of-year 2013-01-01 297
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 243
Number of retired or separated participants receiving benefits 2013-01-01 2
Number of other retired or separated participants entitled to future benefits 2013-01-01 24
Total of all active and inactive participants 2013-01-01 269
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 269
Number of participants with account balances 2013-01-01 249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 19
2012: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2012 401k membership
Total participants, beginning-of-year 2012-01-01 299
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 251
Number of retired or separated participants receiving benefits 2012-01-01 1
Number of other retired or separated participants entitled to future benefits 2012-01-01 24
Total of all active and inactive participants 2012-01-01 276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 276
Number of participants with account balances 2012-01-01 251
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 17
2011: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2011 401k membership
Total participants, beginning-of-year 2011-01-01 281
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 233
Number of retired or separated participants receiving benefits 2011-01-01 2
Number of other retired or separated participants entitled to future benefits 2011-01-01 24
Total of all active and inactive participants 2011-01-01 259
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 259
Number of participants with account balances 2011-01-01 228
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 15
2010: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2010 401k membership
Total participants, beginning-of-year 2010-01-01 260
Total number of active participants reported on line 7a of the Form 5500 2010-01-01 235
Number of retired or separated participants receiving benefits 2010-01-01 2
Number of other retired or separated participants entitled to future benefits 2010-01-01 16
Total of all active and inactive participants 2010-01-01 253
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2010-01-01 0
Total participants 2010-01-01 253
Number of participants with account balances 2010-01-01 223
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2010-01-01 8
2009: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2009 401k membership
Total participants, beginning-of-year 2009-01-01 237
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 207
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 19
Total of all active and inactive participants 2009-01-01 226
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 226
Number of participants with account balances 2009-01-01 200
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 10

Measure	Date	Value
2023: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2023 401k membership
Total participants, beginning-of-year	2023-01-01	408
Total number of active participants reported on line 7a of the Form 5500	2023-01-01	339
Number of retired or separated participants receiving benefits	2023-01-01	0
Number of other retired or separated participants entitled to future benefits	2023-01-01	55
Total of all active and inactive participants	2023-01-01	394
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2023-01-01	0
Total participants	2023-01-01	394
Number of participants with account balances	2023-01-01	370
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2023-01-01	36
2022: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2022 401k membership
Total participants, beginning-of-year	2022-01-01	416
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	326
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	49
Total of all active and inactive participants	2022-01-01	375
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	375
Number of participants with account balances	2022-01-01	357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	40
2021: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2021 401k membership
Total participants, beginning-of-year	2021-01-01	427
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	369
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	51
Total of all active and inactive participants	2021-01-01	420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	420
Number of participants with account balances	2021-01-01	294
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	21
2020: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2020 401k membership
Total participants, beginning-of-year	2020-01-01	452
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	365
Number of retired or separated participants receiving benefits	2020-01-01	1
Number of other retired or separated participants entitled to future benefits	2020-01-01	31
Total of all active and inactive participants	2020-01-01	397
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	397
Number of participants with account balances	2020-01-01	309
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	7
2019: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2019 401k membership
Total participants, beginning-of-year	2019-01-01	431
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	378
Number of retired or separated participants receiving benefits	2019-01-01	4
Number of other retired or separated participants entitled to future benefits	2019-01-01	141
Total of all active and inactive participants	2019-01-01	523
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	524
Number of participants with account balances	2019-01-01	418
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	20
2018: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2018 401k membership
Total participants, beginning-of-year	2018-01-01	421
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	368
Number of retired or separated participants receiving benefits	2018-01-01	2
Number of other retired or separated participants entitled to future benefits	2018-01-01	50
Total of all active and inactive participants	2018-01-01	420
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	2
Total participants	2018-01-01	422
Number of participants with account balances	2018-01-01	297
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	15
2017: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2017 401k membership
Total participants, beginning-of-year	2017-01-01	485
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	420
Number of retired or separated participants receiving benefits	2017-01-01	2
Number of other retired or separated participants entitled to future benefits	2017-01-01	45
Total of all active and inactive participants	2017-01-01	467
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	3
Total participants	2017-01-01	470
Number of participants with account balances	2017-01-01	297
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	16
2016: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2016 401k membership
Total participants, beginning-of-year	2016-01-01	325
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	277
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	38
Total of all active and inactive participants	2016-01-01	315
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	316
Number of participants with account balances	2016-01-01	285
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	18
2015: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2015 401k membership
Total participants, beginning-of-year	2015-01-01	266
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	249
Number of retired or separated participants receiving benefits	2015-01-01	2
Number of other retired or separated participants entitled to future benefits	2015-01-01	33
Total of all active and inactive participants	2015-01-01	284
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	284
Number of participants with account balances	2015-01-01	257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	25
2014: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2014 401k membership
Total participants, beginning-of-year	2014-01-01	292
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	250
Number of retired or separated participants receiving benefits	2014-01-01	1
Number of other retired or separated participants entitled to future benefits	2014-01-01	27
Total of all active and inactive participants	2014-01-01	278
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	278
Number of participants with account balances	2014-01-01	262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	15
2013: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2013 401k membership
Total participants, beginning-of-year	2013-01-01	297
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	243
Number of retired or separated participants receiving benefits	2013-01-01	2
Number of other retired or separated participants entitled to future benefits	2013-01-01	24
Total of all active and inactive participants	2013-01-01	269
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	269
Number of participants with account balances	2013-01-01	249
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	19
2012: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2012 401k membership
Total participants, beginning-of-year	2012-01-01	299
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	251
Number of retired or separated participants receiving benefits	2012-01-01	1
Number of other retired or separated participants entitled to future benefits	2012-01-01	24
Total of all active and inactive participants	2012-01-01	276
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	276
Number of participants with account balances	2012-01-01	251
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	17
2011: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2011 401k membership
Total participants, beginning-of-year	2011-01-01	281
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	233
Number of retired or separated participants receiving benefits	2011-01-01	2
Number of other retired or separated participants entitled to future benefits	2011-01-01	24
Total of all active and inactive participants	2011-01-01	259
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	259
Number of participants with account balances	2011-01-01	228
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	15
2010: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2010 401k membership
Total participants, beginning-of-year	2010-01-01	260
Total number of active participants reported on line 7a of the Form 5500	2010-01-01	235
Number of retired or separated participants receiving benefits	2010-01-01	2
Number of other retired or separated participants entitled to future benefits	2010-01-01	16
Total of all active and inactive participants	2010-01-01	253
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2010-01-01	0
Total participants	2010-01-01	253
Number of participants with account balances	2010-01-01	223
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2010-01-01	8
2009: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2009 401k membership
Total participants, beginning-of-year	2009-01-01	237
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	207
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	19
Total of all active and inactive participants	2009-01-01	226
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	226
Number of participants with account balances	2009-01-01	200
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	10

Financial Data on SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY

Measure	Date	Value
2023 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2023 401k financial data
Total unrealized appreciation/depreciation of assets	2023-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2023-12-31	$0
Total income from all sources (including contributions)	2023-12-31	$4,673,499
Total loss/gain on sale of assets	2023-12-31	$0
Total of all expenses incurred	2023-12-31	$2,544,418
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2023-12-31	$2,462,211
Value of total corrective distributions	2023-12-31	$8,546
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2023-12-31	$1,764,666
Value of total assets at end of year	2023-12-31	$18,236,436
Value of total assets at beginning of year	2023-12-31	$16,107,355
Total of administrative expenses incurred including professional, contract, advisory and management fees	2023-12-31	$73,661
Total interest from all sources	2023-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2023-12-31	$344,995
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2023-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2023-12-31	$344,995
Was this plan covered by a fidelity bond	2023-12-31	Yes
Value of fidelity bond cover	2023-12-31	$500,000
If this is an individual account plan, was there a blackout period	2023-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2023-12-31	No
Contributions received from participants	2023-12-31	$1,145,248
Income. Received or receivable in cash from other sources (including rollovers)	2023-12-31	$338,799
Other income not declared elsewhere	2023-12-31	$603
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Value of net income/loss	2023-12-31	$2,129,081
Value of net assets at end of year (total assets less liabilities)	2023-12-31	$18,236,436
Value of net assets at beginning of year (total assets less liabilities)	2023-12-31	$16,107,355
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2023-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2023-12-31	No
Were any leases to which the plan was party in default or uncollectible	2023-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2023-12-31	$17,136,088
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2023-12-31	$15,008,490
Value of interest in common/collective trusts at end of year	2023-12-31	$1,100,348
Value of interest in common/collective trusts at beginning of year	2023-12-31	$1,098,865
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2023-12-31	$2,514,914
Net investment gain or loss from common/collective trusts	2023-12-31	$48,321
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2023-12-31	No
Was there a failure to transmit to the plan any participant contributions	2023-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2023-12-31	No
Contributions received in cash from employer	2023-12-31	$280,619
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2023-12-31	$2,462,211
Contract administrator fees	2023-12-31	$73,661
Did the plan have assets held for investment	2023-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2023-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2023-12-31	No
Opinion of an independent qualified public accountant for this plan	2023-12-31	Unqualified
Accountancy firm name	2023-12-31	HONKAMP, PC
Accountancy firm EIN	2023-12-31	420946155
2022 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-2,145,400
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$1,201,387
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$1,127,994
Value of total corrective distributions	2022-12-31	$2,532
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$1,220,053
Value of total assets at end of year	2022-12-31	$16,107,355
Value of total assets at beginning of year	2022-12-31	$19,454,142
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$70,861
Total interest from all sources	2022-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$276,180
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$276,180
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$955,457
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$17,203
Other income not declared elsewhere	2022-12-31	$901
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-3,346,787
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$16,107,355
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$19,454,142
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$15,008,490
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$18,513,852
Value of interest in common/collective trusts at end of year	2022-12-31	$1,098,865
Value of interest in common/collective trusts at beginning of year	2022-12-31	$940,290
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-3,654,031
Net investment gain or loss from common/collective trusts	2022-12-31	$11,497
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$247,393
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$1,127,994
Contract administrator fees	2022-12-31	$70,861
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	HONKAMP KRUEGER & CO., P.C.
Accountancy firm EIN	2022-12-31	420946155
2021 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$3,617,399
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,889,351
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,793,123
Value of total corrective distributions	2021-12-31	$18,539
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$1,192,718
Value of total assets at end of year	2021-12-31	$19,454,142
Value of total assets at beginning of year	2021-12-31	$17,726,094
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$77,689
Total interest from all sources	2021-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$304,305
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$304,305
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$923,592
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$44,605
Other income not declared elsewhere	2021-12-31	$1,221
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$1,728,048
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$19,454,142
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$17,726,094
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$18,513,852
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$16,806,067
Value of interest in common/collective trusts at end of year	2021-12-31	$940,290
Value of interest in common/collective trusts at beginning of year	2021-12-31	$920,027
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$2,068,284
Net investment gain or loss from common/collective trusts	2021-12-31	$50,871
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$224,521
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,793,123
Contract administrator fees	2021-12-31	$77,689
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	HONKAMP KRUEGER & CO., P.C.
Accountancy firm EIN	2021-12-31	420946155
2020 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2020 401k financial data
Unrealized appreciation/depreciation of real estate assets	2020-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2020-12-31	$0
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Expenses. Interest paid	2020-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$3,391,815
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,516,921
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,412,938
Value of total corrective distributions	2020-12-31	$37,507
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$1,186,292
Value of total assets at end of year	2020-12-31	$17,726,094
Value of total assets at beginning of year	2020-12-31	$15,851,200
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$66,476
Total income from rents	2020-12-31	$0
Total interest from all sources	2020-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$190,813
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$190,813
Administrative expenses professional fees incurred	2020-12-31	$0
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Amount of non-exempt transactions with any party-in-interest	2020-12-31	$0
Contributions received from participants	2020-12-31	$860,270
Participant contributions at end of year	2020-12-31	$0
Participant contributions at beginning of year	2020-12-31	$13,970
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$107,598
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2020-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2020-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2020-12-31	$0
Other income not declared elsewhere	2020-12-31	$985
Administrative expenses (other) incurred	2020-12-31	$0
Liabilities. Value of operating payables at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Income. Non cash contributions	2020-12-31	$0
Value of net income/loss	2020-12-31	$1,874,894
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$17,726,094
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$15,851,200
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Amount of loans by the plan or fixed income obligations due to the plan which were in default/classified-as-uncollectible as of the close of the plan year	2020-12-31	$0
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Amount of leases to which the plan was a party which were in default/classified-as-uncollectible during the year	2020-12-31	$0
Investment advisory and management fees	2020-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$16,806,067
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$8,520,189
Income. Interest from loans (other than to participants)	2020-12-31	$0
Interest earned on other investments	2020-12-31	$0
Income. Interest from US Government securities	2020-12-31	$0
Income. Interest from corporate debt instruments	2020-12-31	$0
Value of interest in common/collective trusts at end of year	2020-12-31	$920,027
Value of interest in common/collective trusts at beginning of year	2020-12-31	$7,312,495
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2020-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2020-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$2,087,322
Net investment gain/loss from pooled separate accounts	2020-12-31	$0
Net investment gain or loss from common/collective trusts	2020-12-31	$-73,597
Net gain/loss from 103.12 investment entities	2020-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$218,424
Employer contributions (assets) at end of year	2020-12-31	$0
Employer contributions (assets) at beginning of year	2020-12-31	$4,546
Income. Dividends from preferred stock	2020-12-31	$0
Income. Dividends from common stock	2020-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,412,938
Contract administrator fees	2020-12-31	$66,476
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2020-12-31	Yes
Liabilities. Value of benefit claims payable at beginning of year	2020-12-31	$0
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Aggregate proceeds on sale of assets	2020-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2020-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2020-12-31	$0
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	HONKAMP AND KRUEGER & CO., P.C.
Accountancy firm EIN	2020-12-31	420946155
2019 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$3,886,323
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,305,705
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,226,673
Value of total corrective distributions	2019-12-31	$16,128
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$1,166,293
Value of total assets at end of year	2019-12-31	$15,851,200
Value of total assets at beginning of year	2019-12-31	$13,270,582
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$62,904
Total interest from all sources	2019-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$193,301
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$193,301
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$848,666
Participant contributions at end of year	2019-12-31	$13,970
Participant contributions at beginning of year	2019-12-31	$13,376
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$90,654
Administrative expenses (other) incurred	2019-12-31	$62,904
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$2,580,618
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$15,851,200
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$13,270,582
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$8,520,189
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$5,909,450
Value of interest in common/collective trusts at end of year	2019-12-31	$7,312,495
Value of interest in common/collective trusts at beginning of year	2019-12-31	$7,341,129
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$1,433,041
Net investment gain or loss from common/collective trusts	2019-12-31	$1,093,688
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$226,973
Employer contributions (assets) at end of year	2019-12-31	$4,546
Employer contributions (assets) at beginning of year	2019-12-31	$6,627
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,226,673
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2019-12-31	420946155
2018 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$526,284
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$774,112
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$653,235
Value of total corrective distributions	2018-12-31	$55,595
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$1,309,212
Value of total assets at end of year	2018-12-31	$13,270,582
Value of total assets at beginning of year	2018-12-31	$13,518,410
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$65,282
Total interest from all sources	2018-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$149,964
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$149,964
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$890,831
Participant contributions at end of year	2018-12-31	$13,376
Participant contributions at beginning of year	2018-12-31	$18,895
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$210,893
Administrative expenses (other) incurred	2018-12-31	$65,282
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-247,828
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$13,270,582
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$13,518,410
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$5,909,450
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$6,070,460
Value of interest in common/collective trusts at end of year	2018-12-31	$7,341,129
Value of interest in common/collective trusts at beginning of year	2018-12-31	$7,423,582
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-8,272,896
Net investment gain or loss from common/collective trusts	2018-12-31	$7,340,004
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$207,488
Employer contributions (assets) at end of year	2018-12-31	$6,627
Employer contributions (assets) at beginning of year	2018-12-31	$5,473
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$653,235
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2018-12-31	420946155
2017 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets from this plan	2017-12-31	$113,259
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$3,055,125
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$1,570,396
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,494,981
Value of total corrective distributions	2017-12-31	$13,511
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,308,831
Value of total assets at end of year	2017-12-31	$13,518,410
Value of total assets at beginning of year	2017-12-31	$12,146,940
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$61,904
Total interest from all sources	2017-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$123,546
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$123,546
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$850,746
Participant contributions at end of year	2017-12-31	$18,895
Participant contributions at beginning of year	2017-12-31	$17,375
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$252,125
Administrative expenses (other) incurred	2017-12-31	$61,904
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$1,484,729
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$13,518,410
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$12,146,940
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$6,070,460
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$5,438,663
Value of interest in common/collective trusts at end of year	2017-12-31	$7,423,582
Value of interest in common/collective trusts at beginning of year	2017-12-31	$6,685,173
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$885,291
Net investment gain or loss from common/collective trusts	2017-12-31	$737,457
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$205,960
Employer contributions (assets) at end of year	2017-12-31	$5,473
Employer contributions (assets) at beginning of year	2017-12-31	$5,729
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,494,981
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2017-12-31	420946155
2016 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$1,817,849
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$644,864
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$584,399
Value of total corrective distributions	2016-12-31	$3,484
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,180,311
Value of total assets at end of year	2016-12-31	$12,146,940
Value of total assets at beginning of year	2016-12-31	$10,973,955
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$56,981
Total interest from all sources	2016-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$120,630
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$120,630
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$799,395
Participant contributions at end of year	2016-12-31	$17,375
Participant contributions at beginning of year	2016-12-31	$10,322
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$176,823
Administrative expenses (other) incurred	2016-12-31	$56,981
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$1,172,985
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$12,146,940
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$10,973,955
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$5,438,663
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$9,954,047
Value of interest in common/collective trusts at end of year	2016-12-31	$6,685,173
Value of interest in common/collective trusts at beginning of year	2016-12-31	$1,005,321
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$331,356
Net investment gain or loss from common/collective trusts	2016-12-31	$185,552
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$204,093
Employer contributions (assets) at end of year	2016-12-31	$5,729
Employer contributions (assets) at beginning of year	2016-12-31	$4,265
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$584,399
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2016-12-31	420946155
2015 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$905,514
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$613,065
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$537,094
Value of total corrective distributions	2015-12-31	$1,181
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$914,975
Value of total assets at end of year	2015-12-31	$10,973,955
Value of total assets at beginning of year	2015-12-31	$10,681,506
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$74,790
Total interest from all sources	2015-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$291,239
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$291,239
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$715,410
Participant contributions at end of year	2015-12-31	$10,322
Participant contributions at beginning of year	2015-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$14,628
Administrative expenses (other) incurred	2015-12-31	$74,790
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$292,449
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$10,973,955
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$10,681,506
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$9,954,047
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$9,839,485
Value of interest in common/collective trusts at end of year	2015-12-31	$1,005,321
Value of interest in common/collective trusts at beginning of year	2015-12-31	$842,021
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-307,088
Net investment gain or loss from common/collective trusts	2015-12-31	$6,388
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$184,937
Employer contributions (assets) at end of year	2015-12-31	$4,265
Employer contributions (assets) at beginning of year	2015-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$537,094
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2015-12-31	420946155
2014 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$1,569,257
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$458,566
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$386,459
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$969,923
Value of total assets at end of year	2014-12-31	$10,681,506
Value of total assets at beginning of year	2014-12-31	$9,570,815
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$72,107
Total interest from all sources	2014-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$264,111
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$264,111
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$668,864
Participant contributions at beginning of year	2014-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$121,920
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$0
Administrative expenses (other) incurred	2014-12-31	$72,107
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$1,110,691
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$10,681,506
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$9,570,815
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$9,839,485
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$8,749,587
Value of interest in common/collective trusts at end of year	2014-12-31	$842,021
Value of interest in common/collective trusts at beginning of year	2014-12-31	$821,228
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$319,636
Net investment gain or loss from common/collective trusts	2014-12-31	$15,587
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$179,139
Employer contributions (assets) at beginning of year	2014-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$386,459
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2014-12-31	420946155
2013 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$18,582
Total income from all sources (including contributions)	2013-12-31	$2,364,509
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$496,916
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$429,760
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$954,225
Value of total assets at end of year	2013-12-31	$9,570,815
Value of total assets at beginning of year	2013-12-31	$7,721,804
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$67,156
Total interest from all sources	2013-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$500,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$643,355
Participant contributions at end of year	2013-12-31	$0
Participant contributions at beginning of year	2013-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$141,239
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2013-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2013-12-31	$18,582
Administrative expenses (other) incurred	2013-12-31	$67,156
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,867,593
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$9,570,815
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$7,703,222
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$8,749,587
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$6,944,712
Value of interest in common/collective trusts at end of year	2013-12-31	$821,228
Value of interest in common/collective trusts at beginning of year	2013-12-31	$776,851
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$1,389,352
Net investment gain or loss from common/collective trusts	2013-12-31	$20,932
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$169,631
Employer contributions (assets) at end of year	2013-12-31	$0
Employer contributions (assets) at beginning of year	2013-12-31	$241
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$429,760
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2013-12-31	420946155
2012 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$18,582
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$15,794
Total income from all sources (including contributions)	2012-12-31	$1,747,055
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$618,212
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$554,072
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$880,766
Value of total assets at end of year	2012-12-31	$7,721,804
Value of total assets at beginning of year	2012-12-31	$6,590,173
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$64,140
Total interest from all sources	2012-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$500,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$607,768
Participant contributions at end of year	2012-12-31	$0
Participant contributions at beginning of year	2012-12-31	$2,015
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$110,744
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2012-12-31	$18,582
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2012-12-31	$15,794
Administrative expenses (other) incurred	2012-12-31	$64,140
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$1,128,843
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$7,703,222
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$6,574,379
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$6,944,712
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$4,325,845
Value of interest in common/collective trusts at end of year	2012-12-31	$776,851
Value of interest in common/collective trusts at beginning of year	2012-12-31	$2,261,636
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$688,312
Net investment gain or loss from common/collective trusts	2012-12-31	$177,977
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$162,254
Employer contributions (assets) at end of year	2012-12-31	$241
Employer contributions (assets) at beginning of year	2012-12-31	$677
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$554,072
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2012-12-31	420946155
2011 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2011 401k financial data
Total unrealized appreciation/depreciation of assets	2011-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$15,794
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$19,740
Total income from all sources (including contributions)	2011-12-31	$658,515
Total loss/gain on sale of assets	2011-12-31	$0
Total of all expenses incurred	2011-12-31	$554,052
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$478,018
Value of total corrective distributions	2011-12-31	$15,474
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$772,479
Value of total assets at end of year	2011-12-31	$6,590,173
Value of total assets at beginning of year	2011-12-31	$6,489,656
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$60,560
Total interest from all sources	2011-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2011-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$500,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$614,241
Participant contributions at end of year	2011-12-31	$2,015
Participant contributions at beginning of year	2011-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2011-12-31	$15,794
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2011-12-31	$19,740
Administrative expenses (other) incurred	2011-12-31	$60,560
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$104,463
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$6,574,379
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$6,469,916
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2011-12-31	$4,325,845
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2011-12-31	$3,900,662
Value of interest in common/collective trusts at end of year	2011-12-31	$2,261,636
Value of interest in common/collective trusts at beginning of year	2011-12-31	$2,588,994
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-144,167
Net investment gain or loss from common/collective trusts	2011-12-31	$30,203
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$158,238
Employer contributions (assets) at end of year	2011-12-31	$677
Employer contributions (assets) at beginning of year	2011-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$478,018
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	HONKAMP KRUEGER & CO PC
Accountancy firm EIN	2011-12-31	420946155
2010 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$19,740
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$26,143
Total income from all sources (including contributions)	2010-12-31	$1,569,726
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$340,116
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$266,374
Value of total corrective distributions	2010-12-31	$19,430
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$837,873
Value of total assets at end of year	2010-12-31	$6,489,656
Value of total assets at beginning of year	2010-12-31	$5,266,449
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$54,312
Total interest from all sources	2010-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$500,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$669,982
Participant contributions at end of year	2010-12-31	$0
Participant contributions at beginning of year	2010-12-31	$22,919
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$9,319
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2010-12-31	$19,740
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$26,143
Administrative expenses (other) incurred	2010-12-31	$54,312
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$1,229,610
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$6,469,916
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$5,240,306
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$3,900,662
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$3,007,331
Value of interest in common/collective trusts at end of year	2010-12-31	$2,588,994
Value of interest in common/collective trusts at beginning of year	2010-12-31	$2,230,056
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$540,001
Net investment gain or loss from common/collective trusts	2010-12-31	$191,852
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$158,572
Employer contributions (assets) at end of year	2010-12-31	$0
Employer contributions (assets) at beginning of year	2010-12-31	$6,143
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$266,374
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2010-12-31	No
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	HONKAMP KRUEGER & CO, PC
Accountancy firm EIN	2010-12-31	420946155
2009 : SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY

2023: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2023 form 5500 responses
2023-01-01	Type of plan entity	Single employer plan
2023-01-01	This submission is the final filing	No
2023-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2023-01-01	Plan is a collectively bargained plan	No
2023-01-01	Plan funding arrangement – Trust	Yes
2023-01-01	Plan benefit arrangement - Trust	Yes
2022: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2010: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2010 form 5500 responses
2010-01-01	Type of plan entity	Single employer plan
2010-01-01	Submission has been amended	No
2010-01-01	This submission is the final filing	No
2010-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2010-01-01	Plan is a collectively bargained plan	No
2010-01-01	Plan funding arrangement – Trust	Yes
2010-01-01	Plan benefit arrangement - Trust	Yes
2009: SAVINGS PLAN FOR EMPLOYEES OF HARTIG DRUG COMPANY 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	HARTIG DRUG COMPANY
Employer identification number (EIN):	420298860
NAIC Classification:	446110
NAIC Description:	Pharmacies and Drug Stores

Jurisdiction of Incorporation:	Iowa Secretary of State Business Entities
Incorporation Date:	1917-02-24
Company Identification Number:	017939
Legal Registered Office Address:	703 MAIN ST DUBUQUE United States of America (USA) 52001